Second Measles Case Confirmed in Rhode Island for 2026
Rhode Island health officials have confirmed the state’s second case of measles in 2026, involving a woman in her 20s who had recently traveled from outside the United States to visit family in the state. The case was identified after she sought treatment at Brown University Health Urgent Care in Middletown on April 24, 2026, and subsequently tested positive for the virus at the Rhode Island State Health Laboratories. She did not require hospitalization.
This case is unrelated to the first measles case reported in Rhode Island earlier in April 2026, which was identified on April 18. State health officials emphasized that there is no known link between the two cases and that the patient did not report visiting any other locations in Rhode Island after her arrival.
In response, the Rhode Island Department of Health, in coordination with Brown University Health, has begun outreach efforts to individuals who may have been exposed to the virus at the Middletown urgent care center. Health officials advise anyone who believes they may have been exposed and begins to develop symptoms of measles—such as fever, cough, runny nose, red eyes, or a characteristic rash—to contact their healthcare provider before visiting a medical facility to prevent potential transmission in waiting rooms or common areas.
Measles is a highly contagious viral illness spread through respiratory droplets when an infected person coughs or sneezes. The virus can remain airborne for up to two hours after an infected person leaves an area. Even as measles can lead to serious complications, including pneumonia and encephalitis, it is preventable through vaccination.
The measles, mumps, and rubella (MMR) vaccine is highly effective, with two doses providing about 97% protection against measles. The first dose is typically administered between 12 and 15 months of age, and the second dose between 4 and 6 years classic. According to the Rhode Island Department of Health, approximately 97% of kindergarteners in the state have completed the MMR vaccine series, contributing to strong community immunity.
“The chance of significant spread of measles in Rhode Island is very low because we have such a high MMR vaccination rate,” said Dr. Jerry Larkin, Director of Health for Rhode Island. “But that degree of community protection depends on everyone who is eligible getting vaccinated.”
Health officials continue to urge residents to ensure they are up to date on MMR vaccinations, particularly before international travel. Individuals who are unsure of their vaccination status or who have not received two doses of the MMR vaccine should consult a healthcare provider. For families facing barriers to access, such as cost or insurance issues, the Rhode Island Department of Health offers the MMR vaccine at no cost through public health clinics.
As of this report, no additional measles cases have been identified in Rhode Island linked to this investigation. Health authorities will continue to monitor the situation and provide updates as needed.